Pursuant to Regulation 29 30 and 42 of SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015 (SEBI LODR), Amrutanjan Health Care has informed about a meeting of the Board of Directors is scheduled to be held on Monday, August 14, 2017 at the registered office of the Company to consider and approve the Un-audited Financial Results along with the Limited Review Report for the quarter ended June 30, 2017; and Fix record date for the payment of dividend subject to the approval of the shareholders. In view of the above, as per the SEBI (Prohibition of Insider Trading) Regulations, 2015 and the Company’s Code of Conduct to regulate, monitor and report trading by insiders, the trading window for dealing in the securities of the Company shall remain closed for the Specified Persons (Directors & Designated Employees) from August 7, 2017 to August 16, 2017.
The above information is a part of company’s filings submitted to BSE.
